Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : Barclays remains Neutral

11/12/2020 | 07:34am EST

Emily Field from Barclays retains his Neutral opinion on the stock. The target price is still set at EUR 125.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
BARCLAYS PLC -3.34% 146.36 Delayed Quote.3.16%
MERCK KGAA 0.03% 148.85 Delayed Quote.6.02%
All news about MERCK KGAA
01/14KONINKLIJKE PHILIPS N : Philips Teams Up With Merck to Develop Digital Products ..
MT
01/14DGAP-PVR : Merck KGaA: Release according to -4-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to -3-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to -2-
DJ
01/14DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
01/13MERCK KGAA : JP Morgan keeps its Buy rating
MD
01/11DGAP-PVR : Merck KGaA: Release according to -6-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -5-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -4-
DJ
01/11DGAP-PVR : Merck KGaA: Release according to -3-
DJ
More news
Financials
Sales 2020 17 359 M 21 047 M 21 047 M
Net income 2020 1 973 M 2 392 M 2 392 M
Net Debt 2020 11 104 M 13 462 M 13 462 M
P/E ratio 2020 32,6x
Yield 2020 0,94%
Capitalization 64 695 M 78 134 M 78 436 M
EV / Sales 2020 4,37x
EV / Sales 2021 4,06x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 137,28 €
Last Close Price 148,80 €
Spread / Highest target 13,6%
Spread / Average Target -7,74%
Spread / Lowest Target -32,1%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA6.02%78 134
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD7.10%26 625
KYOWA KIRIN CO., LTD.0.21%14 610
BETTA PHARMACEUTICALS CO., LTD.18.12%7 873
YUHAN CORPORATION-3.99%4 063
RECIPHARM AB (PUBL)2.10%2 693